High expression of Met/hepatocyte growth factor receptor suppresses tumorigenicity in NCI-H1264 lung carcinoma cells.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Experimental Cell Research

• Publication date

  2002-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1006/EXCR.2001.5433PMID 11795945
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cyclin D1 overexpression in a model of human breast premalignancy: preferential stimulation of anchorage-independent but not anchorage-dependent growth is associated with increased cdk2 activity

  2004cited by this paper
• Inhibition of anchorage-independent growth and lung metastasis of A549 lung carcinoma cells by IκBβ

  2001cited by this paper
• Inhibition of anchorage-independent growth and lung metastasis of A549 lung carcinoma cells by IkappaBbeta.

  2001cited by this paper
• Ral promotes anchorage-independent growth of a human fibrosarcoma, HT1080.

  2001cited by this paper
• Suppression of ras-mediated transformation and inhibition of tumor growth and angiogenesis by anthrax lethal factor, a proteolytic inhibitor of multiple MEK pathways

  2001cited by this paper
• Osteopontin is required for full expression of the transformed phenotype by the ras oncogene

  2000cited by this paper
• Activation of hepatocyte growth factor-met autocrine loop enhances tumorigenicity in a human lung adenocarcinoma cell line.

  2000cited by this paper
• Transfection of constitutively active mitogen-activated protein/extracellular signal-regulated kinase kinase confers tumorigenic and metastatic potentials to NIH3T3 cells.

  2000cited by this paper
• Inhibition of MAP kinase kinase causes morphological reversion and dissociation between soft agar growth and in vivo tumorigenesis in angiosarcoma cells.

  2000cited by this paper
• Met-HGF/SF mediates growth arrest and differentiation in T47D breast cancer cells.

  1999cited by this paper
• Decreased fibronectin expression in Met/HGF-mediated tumorigenesis

  1998cited by this paper
• Ras Signals to the Cell Cycle Machinery via Multiple Pathways To Induce Anchorage-Independent Growth

  1998cited by this paper
• Differential expression of Met/hepatocyte growth factor receptor in subtypes of non-small cell lung cancers.

  1998cited by this paper
• Hepatocyte growth factor/scatter factor (HGF/SF) induces vascular permeability factor (VPF/VEGF) expression by cultured keratinocytes.

  1998cited by this paper
• p125Fak Focal Adhesion Kinase Is a Substrate for the Insulin and Insulin-like Growth Factor-I Tyrosine Kinase Receptors*

  1998cited by this paper
• Paracrine effects of hepatocyte growth factor/scatter factor on non-small-cell lung carcinoma cell lines.

  1998cited by this paper
• Reexpression of the type 1 insulin-like growth factor receptor inhibits the malignant phenotype of simian virus 40 T antigen immortalized human prostate epithelial cells.

  1997cited by this paper
• Scatter factor/hepatocyte growth factor gene transfer enhances glioma growth and angiogenesis in vivo.

  1997cited by this paper
• Type-1 insulin-like growth factor receptor reexpression in the malignant phenotype of SV40-T-immortalized human prostate epithelial cells enhances apoptosis

  1997cited by this paper
• Scatter factor stimulates tumor growth and tumor angiogenesis in human breast cancers in the mammary fat pads of nude mice.

  1997cited by this paper
• Integrins, Oncogenes, and Anchorage Independence

  1997cited by this paper
• Inhibitory effect of hepatocyte growth factor on metastasis of hepatocellular carcinoma in transgenic mice.

  1996cited by this paper
• Autocrine hepatocyte growth factor/scatter factor-Met signaling induces transformation and the invasive/metastastic phenotype in C127 cells.

  1996cited by this paper
• Inhibition of neoplastic development in the liver by hepatocyte growth factor in a transgenic mouse model.

  1996cited by this paper
• Enhanced tumorigenicity and invasion-metastasis by hepatocyte growth factor/scatter factor-met signalling in human cells concomitant with induction of the urokinase proteolysis network

  1996cited by this paper
• STK/RON receptor tyrosine kinase mediates both apoptotic and growth signals via the multifunctional docking site conserved among the HGF receptor family.

  1996cited by this paper
• A family of transmembrane proteins with homology to the MET-hepatocyte growth factor receptor.

  1996cited by this paper
• Transgenic expression of tpr-met oncogene leads to development of mammary hyperplasia and tumors.

  1996cited by this paper
• NCI‐navy medical oncology branch cell line data base

  1996cited by this paper
• Induction of tyrosine phosphorylation and translocation of ezrin by hepatocyte growth factor/scatter factor.

  1995cited by this paper
• Association of p120, a tyrosine kinase substrate, with E- cadherin/catenin complexes

  1995cited by this paper
• Selective tumorigenesis in non-parenchymal liver epithelial cell lines by hepatocyte growth factor transfection.

  1995cited by this paper
• Hepatocyte growth factor/scatter factor induces tyrosine phosphorylation of focal adhesion kinase (p125FAK) and promotes migration and invasion by oral squamous cell carcinoma cells.

  1994cited by this paper
• Invasiveness and metastasis of NIH 3T3 cells induced by Met-hepatocyte growth factor/scatter factor autocrine stimulation.

  1994cited by this paper
• Inhibitory effect of hepatocyte growth factor against FaO hepatocellular carcinoma cells may be associated with changes of intracellular signalling pathways mediated by protein kinase C.

  1994cited by this paper
• Creation of an hepatocyte growth factor/scatter factor autocrine loop in carcinoma cells induces invasive properties associated with increased tumorigenicity.

  1994cited by this paper
• Hepatocyte growth factor transforms immortalized mouse liver epithelial cells.

  1993cited by this paper
• Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth

  1992cited by this paper
• Hepatocyte growth factor inhibits growth of hepatocellular carcinoma cells.

  1992cited by this paper
• A fibroblast-derived tumor cytotoxic factor/F-TCF (hepatocyte growth factor/HGF) has multiple functions in vitro.

  1991cited by this paper
• Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product.

  1991cited by this paper
• Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor.

  1991cited by this paper
• Hepatocyte growth factor has potent anti‐proliferative activity in various tumor cell lines

  1991cited by this paper
• Hepatocytes and scatter factor

  1990cited by this paper
• Vascular endothelial growth factor is a secreted angiogenic mitogen.

  1989cited by this paper
• Molecular cloning and expression of human hepatocyte growth factor

  1989cited by this paper
• Purification of scatter factor, a fibroblast-derived basic protein that modulates epithelial interactions and movement.

  1989cited by this paper
• Sequence of MET protooncogene cDNA has features characteristic of the tyrosine kinase family of growth-factor receptors.

  1987cited by this paper
• Tumorigenicity of virus-transformed cells in nude mice is correlated specifically with anchorage independent growth in vitro.

  1975cited by this paper

• [A simple view on lung cancer biology: the MET pathway].

  2011cites this paper
• MET Gene Copy Number in Non-small Cell Lung Cancer: Molecular Analysis in a Targeted Tyrosine Kinase Inhibitor Naïve Cohort

  2008cites this paper
• Gab1 but not Grb2 mediates tumor progression in Met overexpressing colorectal cancer cells.

  2008cites this paper
• A Functional Screen Identifies miR-34a as a Candidate Neuroblastoma Tumor Suppressor Gene

  2008influential citation
• Immunoregulation by hepatocyte growth factor in malignant mesothelioma

  2008cites this paper
• Hepatocyte Growth Factor Receptor c-MET Is Associated with FAS and When Activated Enhances Drug-induced Apoptosis in Pediatric B Acute Lymphoblastic Leukemia with TEL-AML1 Translocation*

  2007cites this paper
• Involvement of HGF/SF–Met signaling in prostate adenocarcinoma cells: Evidence for alternative mechanisms leading to a metastatic phenotype in Pr‐14c

  2005cites this paper
• Allelic imbalance at loci containing FGFR, FGF, c-Met and HGF candidate genes in non-small cell lung cancer sub-types, implication for progression.

  2003cites this paper
• Met receptor overexpression and oncogenic Ki-ras mutation cooperate to enhance tumorigenicity of colon cancer cells in vivo.

  2003cites this paper